Recombinant EGFR (Cetuximab Biosimilar) antibody (PE)

Catalog No. ABIN7829124

The PE-conjugated Humanized Chimeric anti-EGFR (Cetuximab Biosimilar) antibody (ABIN7829124) specifically detects EGFR (Cetuximab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant EGFR (Cetuximab Biosimilar) antibody (PE) (ABIN7829124)

Target: EGFR (Cetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This EGFR (Cetuximab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-EGFR (Cetuximab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-EGFR (Cetuximab biosimilar) mAb

Isotype: IgG1, kappa

Application Details

Application Notes: Flow Cyt 0.5 μL:test

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid,PBS with,0.18 % BSA,0.1 %Proclin300

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for EGFR (Cetuximab Biosimilar)

Target: EGFR (Cetuximab Biosimilar)

Alternative Name: Cetuximab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:EGFR,ERBB,ERBB1,HER1,PIG61,mENA
Synonyms Antibody:Fab C225,IMC-225

UniProt: P00533